Thursday, June 22, 2017

Systems pharmacology modelers accelerate drug discovery in Alzheimer's

An InSysBio scientific group led by Tatiana Karelina has developed a quantitative system pharmacology model of Alzheimer’s disease. The first part has been published in CPT Pharmacometrics & Systems Pharmacology, and shows how to design initial phases of clinical trials of new drugs and to interpret the data.

from Dementia Big http://ift.tt/2sEwgMZ via alcoholic dementia


http://ift.tt/2sYGGtN

No comments:

Post a Comment